康芝药业获上市公司ESG评级A级

Core Viewpoint - The recent ESG proactive rating results released by Hainan Green Development Credit Rating Co., Ltd. cover 5,393 listed companies, aiming to support enterprises in their green transformation and provide transparent references for investors and regulatory bodies [1] Group 1: ESG Rating Overview - The ESG rating framework includes three dimensions: Environment (E), Social (S), and Governance (G), encompassing 19 core topics and over 300 data indicators to derive a comprehensive ESG rating score [1] - Approximately 30% of the rated companies achieved an A grade or above, indicating a significant level of recognition for sustainable practices among listed firms [1] Group 2: Company-Specific Insights - Kangzhi Pharmaceutical Co., Ltd. received an A grade in the ESG rating, reflecting its comprehensive performance in sustainability and recognition of its efforts in corporate social responsibility [1] - The company is committed to advancing the children's health industry and aims to contribute to the construction of a "Healthy China" and a better society through its sustainable development initiatives [1]